Patton Medical Devices, a company out of Austin, Texas, is working on bringing onto the market its I-PORT™ medication injection port. Thought to be used primarily by diabetics, the port is designed for subcutaneous drug delivery.
From company’s website:
The I-PORT™ functions as a medication delivery channel directly into the subcutaneous tissue (the tissue layer located just beneath the skin). When applying the I-PORT™, an insertion needle guides a soft cannula (a small, flexible tube) under the skin. Once applied, the insertion needle is removed and only the soft cannula remains below the skin, acting as the gateway into the subcutaneous tissue.
To inject through the I-PORT™, the needle of a syringe or insulin pen is used. The needle remains above the surface of the skin, while the medication is immediately delivered through the soft cannula and into the subcutaneous tissue.
According to the company, its device, that measures only 1.5″ (38mm) in diameter and 1/3″ (9mm) in height, can accommodate as many as 75 injections every 72 hours. That is some tight glycemic control!
The I-PORT™ is expected to be available in the U.S. in early 2007.